| A Phase I/II Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma (NCT06049290) | Nanjing Leads Biolabs Co.,Ltd | 2023-10-20 |
| Treating Exacerbations of Asthma With Oral Montelukast in Children (NCT05819541) | Vanderbilt University Medical Center | 2023-10-20 |
| Phase II Clinical Trial of the Inactivated Rotavirus Vaccine (NCT06080906) | Institute of Medical Biology, Chinese Academy of Medical Sciences | 2023-10-20 |
| Randomized Phase II Study of ADT + Abiraterone vs ADT + Docetaxel + Abiraterone (NCT06060587) | Northwestern University | 2023-10-19 |
| Potential Protective Role of SGLT-2 Inhibitors for Chemotherapy-induced Cardiotoxicity (NCT06341842) | Fondazione IRCCS Policlinico San Matteo di Pavia | 2023-10-19 |
| Hypofractionated Radiation Therapy After Durvalumab and Chemotherapy for the Treatment of Stage IV Extensive Stage Small Cell Lung Cancer, CASPIAN-RT Trial (NCT05161533) | University of Washington | 2023-10-19 |
| Monovalent Chimpanzee Adenoviral-Vectored Marburg Virus Vaccine in Healthy Adults (NCT05817422) | Albert B. Sabin Vaccine Institute | 2023-10-19 |
| A Study of CT-868 in Type 1 Diabetes Mellitus (NCT06062069) | Carmot Therapeutics, Inc. | 2023-10-19 |
| Evaluation of Infigratinib in Patients With Locally Advanced or Metastatic Gastric Cancer or GEJ Adenocarcinoma (NCT06206278) | LianBio LLC | 2023-10-19 |
| Prolonged Ultra Low-dose Decitabine Plus Venetoclax for Primary Diagnosed Elderly AMLK/MDS (NCT06046313) | First Affiliated Hospital of Zhejiang University | 2023-10-19 |
| A Study of BN104 in the Treatment of Acute Leukemia (NCT06052813) | Institut de Recherches Internationales Servier (I.R.I.S.) | 2023-10-19 |
| Prednisone Plus IVIg vs. Prednisone for ITP During Pregnancy (NCT06577909) | Peking University People's Hospital | 2023-10-19 |
| Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Cancer as a Tool to Select Those Who May Benefit From the Next Course of Fulvestrant in Combination With Alpelisib or Ribociclib (NCT05625087) | UNICANCER | 2023-10-19 |
| Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor (NCT05616650) | National Cancer Institute (NCI) | 2023-10-19 |
| A Study of IBI363 in Subjects With Advanced Melanoma (NCT06081920) | Innovent Biologics (Suzhou) Co. Ltd. | 2023-10-19 |
| Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D) (NCT05743244) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2023-10-19 |
| Impact of Cilostazol Versus Cilostazol and Selenium Combination on the Healing of Diabetic Foot Ulcer Patients (NCT06117436) | Ain Shams University | 2023-10-19 |
| First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer (NCT06063070) | Sun Yat-sen University | 2023-10-18 |
| Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (PLOF) for Resectable Locally Advanced Gastric Cancer (NCT06054906) | Huashan Hospital | 2023-10-18 |
| A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer (NCT06099769) | Memorial Sloan Kettering Cancer Center | 2023-10-18 |
| A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC (NCT05968326) | Genentech, Inc. | 2023-10-18 |
| A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer (NCT05902988) | Volastra Therapeutics, Inc. | 2023-10-18 |
| Testing the Addition of Radiation Therapy to the Immune Therapy Treatment for ES-SCLC (NCT06350162) | Zhejiang Cancer Hospital | 2023-10-18 |
| Nimotuzumab Combined With mFOLFIRINOX/GX as Postoperative Adjuvant Therapy in Pancreatic Cancer (NCT06389760) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2023-10-18 |
| A Study of Local Envafolimab Injection Combined With Chemotherapy in Non-small Cell Lung Cancer (NCT06108726) | Northern Jiangsu People's Hospital | 2023-10-18 |
| Safety and Efficacy of Allogeneic HPV-specific T Cells in Adults With Recurrent or Metastatic HPV16+ Cancers (NCT04713046) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2023-10-18 |
| Managing Opioid Related Sleep Apnea With Acetazolamide (NCT06043830) | University of California, San Diego | 2023-10-18 |
| Effects of Mulligan Technique With or Without Diclofenac Phonophoresis on Patellofemoral Pain Syndrome. (NCT06439251) | University of Lahore | 2023-10-18 |
| Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Age (NCT05871970) | Protara Therapeutics | 2023-10-18 |
| A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1) (NCT06041256) | Aurion Biotech | 2023-10-18 |
| Reishi Mushroom Extract for Fatigue and/or Arthralgias/Myalgias in Patients With Breast Cancer on Aromatase Inhibitors (NCT06028022) | Mayo Clinic | 2023-10-18 |
| Efficacy and Safety of Obinutuzumab Versus Rituximab in Childhood Steroid Dependant and Frequent Relapsing Nephrotic Syndrome (NCT05786768) | Assistance Publique - Hôpitaux de Paris | 2023-10-18 |
| Open Label Phase 2 Basket Trial With Atezolizumab and Tiragolumab in Solid Tumors (NCT05483400) | University Medical Center Groningen | 2023-10-18 |
| G3P-01 in Volunteers With Elevated Galectin-3 (NCT06398821) | General Practitioners Research Institute | 2023-10-18 |
| BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients (NCT05363709) | M.D. Anderson Cancer Center | 2023-10-18 |
| Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage (NCT05853601) | Medical College of Wisconsin | 2023-10-17 |
| A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study). (NCT05975905) | Keros Therapeutics, Inc. | 2023-10-17 |
| De-escalation Radiation Strategy After NAC in Combination With ICI in LAHNSCC (NCT06572514) | Ruijin Hospital | 2023-10-17 |
| A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors. (NCT05944224) | Shanghai Pharmaceuticals Holding Co., Ltd | 2023-10-17 |
| ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST (NCT05366816) | University of Miami | 2023-10-17 |
| First-line Maintenance of OH2 Injection for Advanced Colorectal Cancer (NCT05648006) | Binhui Biopharmaceutical Co., Ltd. | 2023-10-17 |
| Semaglutide Therapy for Alcohol Reduction (STAR) (NCT06015893) | National Institute on Drug Abuse (NIDA) | 2023-10-17 |
| Combination Niraparib and Dostarlimab Therapy for Recurrent or Persistent Uterine Serous Carcinoma (NCT05870761) | Casey Cosgrove | 2023-10-17 |
| Experimental Study on Alcohol Use and Behavior in Young Adults (NCT06199076) | Karolinska Institutet | 2023-10-17 |
| Phentermine/Topiramate as Preventive Pharmacotherapy for Obesity (NCT05834062) | University of Minnesota | 2023-10-17 |
| Single Nuclei RNA-seq to Map Adipose Cellular Populations and Senescent Cells in Older Subjects (NCT05653258) | Cedars-Sinai Medical Center | 2023-10-17 |
| Comparative Effects of Autologous Serum, Umbilical Cord Blood-Derived Drops, and Platelet Lysate on Ocular Surface Parameters (NCT07551843) | G.Gennimatas General Hospital | 2023-10-17 |
| A Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution for Dry Eye in Adult Participants (NCT05992922) | Iacta Pharmaceuticals | 2023-10-17 |
| A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer (NCT06111274) | Abbisko Therapeutics Co, Ltd | 2023-10-17 |
| A Study of HS-20094 Evaluating Weight Loss in Obese and Overweight Chinese Subjects (NCT06118021) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2023-10-16 |
| A Phase Ib/II Clinical Study of AK127 in Combination With AK112 in Patients With Advanced Solid Tumors (NCT05951608) | Akeso | 2023-10-16 |
| A Phase II Clinical Study of Cadonilimab in Treatment-naïve or Relapsed Extensive Small Cell Lung Cancer (NCT06406673) | Henan Cancer Hospital | 2023-10-16 |
| Phase 2/3 Heterologous Boosting Study With Different Dose Levels of Monovalent SARS-CoV-2 rS Vaccines (NCT05925127) | Novavax | 2023-10-16 |
| Radiotherapy in Patients With Metastatic Esophageal Cancer Responding to PD-1 Inhibitor Plus Chemotherapy (NCT06084897) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2023-10-16 |
| Semaglutide in CFRD (NCT05788965) | University of Minnesota | 2023-10-16 |
| A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Elevated hsCRP (NCT06031844) | Novartis Pharmaceuticals | 2023-10-16 |
| The Efficacy and Safety of Hetrombopag as Secondary Prevention to Chemotherapy-induced Thrombocytopenia in Patients With Gynecologic Malignancies (NCT06099925) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2023-10-16 |
| Dose Ranging Study of Lunsekimig Compared With Placebo-control in Adult Participants With Moderate-to-severe Asthma (NCT06102005) | Sanofi | 2023-10-16 |
| A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS) (NCT06083922) | Memorial Sloan Kettering Cancer Center | 2023-10-16 |
| Safety and Impact of Dasatinib on Viral Persistence and Inflammation in People With HIV Under Antiretroviral Treatment (NCT05780073) | Fundació Institut Germans Trias i Pujol | 2023-10-16 |
| Graves' Disease Remission Study: MycoMeth Combo (NCT06068179) | The First Affiliated Hospital of Xiamen University | 2023-10-16 |
| Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer (NCT05828082) | National Cancer Institute (NCI) | 2023-10-16 |
| SMILES: Study of Montelukast in Sickle Cell Disease (NCT04351698) | Great Ormond Street Hospital for Children NHS Foundation Trust | 2023-10-16 |
| PK/Efficacy Bridging Study of ASTX727 in Chinese Subjects With Myelodysplastic Syndromes (NCT06091267) | Otsuka Beijing Research Institute | 2023-10-16 |
| Efficacy and Safety of HRS9531 Injections in Overweight or Obese Subjects (NCT06054698) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2023-10-16 |
| The Efficacy and Safety of TAS-102(Suyuan) Combined With Bevacizumab as First-line Therapy in Patients With Advanced Colorectal Cancer (NCT06092242) | The Second Affiliated Hospital of Shandong First Medical University | 2023-10-15 |
| Assessing the Effectiveness and Safety of Interferon Bladder Infusion for the Treatment of Interstitial Cystitis (NCT05912946) | West China Hospital | 2023-10-15 |
| Effect of Metformin as Add-on Therapy to Ibuprofen on Disease Activity in Knee Osteoarthritis Patients. (NCT06126029) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2023-10-15 |
| Valacyclovir Plus Celecoxib for Post-Acute Sequelae of SARS-CoV-2 (NCT06316843) | Bateman Horne Center | 2023-10-15 |
| A Pharmacokinetics and Safety Study of Augmentin ES-600 in Children With CAP and ABRS (NCT05340257) | GlaxoSmithKline | 2023-10-14 |
| Evaluation of the Bimatoprost Implant System Used in Combination With the SpyGlass Intraocular Lens Compared to Timolol Ophthalmic Solution (NCT06120842) | SpyGlass Pharma, Inc. | 2023-10-13 |
| Levosimendan as Treatment of Aneurysmal SubArachnoid Haemorrhage (NCT05664191) | Assistance Publique - Hôpitaux de Paris | 2023-10-13 |
| Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer (NCT05854498) | University of Wisconsin, Madison | 2023-10-13 |
| Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer (NCT06677944) | Yonsei University | 2023-10-13 |
| DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers (NCT05882058) | Boehringer Ingelheim | 2023-10-13 |
| The Impact of Granulocyte Colony Stimulating Factor on Premature Ovarian Insufficiency (NCT06117982) | Trio Fertility | 2023-10-13 |
| Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer (NCT05318469) | Yuan Yuan | 2023-10-13 |
| A Study of BGM0504 Evaluating Weight Loss in Overweight or Obese Chinese Subjects (NCT06973681) | BrightGene Bio-Medical Technology Co., Ltd. | 2023-10-13 |
| DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic Dysphonia (NCT05158166) | University of California, San Francisco | 2023-10-13 |
| Testing Immunotherapy for Patients With Liver Cancer and Moderately Altered Liver Functions (NCT05622071) | UNICANCER | 2023-10-12 |
| A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome (NCT05804669) | Crinetics Pharmaceuticals Inc. | 2023-10-12 |
| Study With NVDX3 for Treatment of Low Grade Degenerative Lumbar Spondylolisthesis (NCT05961956) | Novadip Biosciences | 2023-10-12 |
| Clinical Trial to Assess Efficacy, Tolerability of Rising Doses of Clodronate in Painful Knee Osteoarthritis Patients (NCT06263517) | SPA Società Prodotti Antibiotici S.p.A. | 2023-10-12 |
| Zanubrutinib+Lenalidomide+R-ICE in Relapsed/Refractory DLBCL (NCT06033820) | RenJi Hospital | 2023-10-12 |
| A Study of EXG102-031 in Participants With wAMD (NCT06183814) | Guangzhou Jiayin Biotech Ltd | 2023-10-12 |
| Safety and Preliminary Efficacy of TISA-818 Injection in Patients With Acute Respiratory Distress Syndrome (NCT07319351) | EnliTISA (Shanghai) Pharmaceutical Co., Ltd. | 2023-10-12 |
| Milademetan and Fulvestrant in GATA3-mutant, ER+HER- Advanced or Metastatic Breast Cancer (NCT05932667) | Institut Curie | 2023-10-12 |
| A Phase 2 Trial of GlOfitamab anD pIrtobrutinib in Mantle Cell Lymphoma Patients With Prior BTK Inhibitor Exposure. (NCT05833763) | Australasian Leukaemia and Lymphoma Group | 2023-10-12 |
| Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial (NCT05564416) | National Cancer Institute (NCI) | 2023-10-12 |
| SS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand Treatment (NCT06010953) | Hangzhou Gensciences Biopharmaceutical Co., Ltd. | 2023-10-12 |
| Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery (NCT05766891) | M.D. Anderson Cancer Center | 2023-10-12 |
| NMDA-enhancing Treatment for Cognitive Dysfunction of Schizophrenia (NCT06021197) | China Medical University Hospital | 2023-10-12 |
| Study of SAR447537 (INBRX-101) Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema (NCT05856331) | Sanofi | 2023-10-12 |
| Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory Distress (NCT06026163) | Ministry of Health, Saudi Arabia | 2023-10-12 |
| A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion or Subcutaneous (SC) Injection of Budigalimab and/or ABBV-382 (NCT06032546) | AbbVie | 2023-10-12 |
| Efficacy and Safety of MC2-25 Cream & Vehicle in Women With Vulvar Lichen Sclerosus (VLS) (NCT06132919) | MC2 Therapeutics | 2023-10-11 |
| Fingolimod in Minimal Invasive Treatment of Intracerebral Hemorrhage (NCT06087965) | Tang-Du Hospital | 2023-10-11 |
| Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) (NCT06112340) | Sling Therapeutics, Inc. | 2023-10-11 |
| A Clinical Trial on the Safety and Efficacy of TQB3909 Tablets in Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) . (NCT05959694) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-10-11 |
| A Study of RBD1016 in CHB Participants (NCT05961098) | Suzhou Ribo Life Science Co. Ltd. | 2023-10-11 |